Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit, J Pediatr, vol.123, issue.4, pp.579-82, 1993. ,
Growth and body composition in children infected with the human immunodeficiency virus-1, Am J Clin Nutr, vol.57, issue.4, pp.588-92, 1993. ,
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group, J Pediatr, vol.128, issue.1, pp.58-69, 1996. ,
Longitudinal assessment of growth in children born to mothers with human immunodeficiency virus infection, Arch Pediatr Adolesc Med, vol.149, issue.5, pp.497-502, 1995. ,
Growth failure in children with HIV infection, J Acquir Immune Defic Syndr, vol.25, issue.1, pp.37-42, 2000. ,
Barros Filho A. Evolution of nutritional status of infants infected with the human immunodeficiency virus, Sao Paulo Med J, vol.118, issue.5, pp.148-53, 2000. ,
Child Growth According to Maternal and Child HIV Status in Zimbabwe, Pediatr Infect Dis J, vol.36, issue.9, pp.869-76, 2017. ,
Growth and pubertal development in HIV-infected adolescents, Curr Opin HIV AIDS, vol.13, issue.3, pp.179-86, 2018. ,
Influence of AIDS antiretroviral therapy on the growth pattern, J Pediatr, vol.95, issue.1, pp.7-17, 2019. ,
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia, J Adolesc Health, vol.58, issue.4, pp.451-460, 2016. ,
Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy, J Pediatr Infect Dis Soc, vol.6, issue.3, pp.109-124, 2017. ,
Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-infected Children Treated Before the Age of 2 Years in West Africa, Pediatr Infect Dis J, vol.37, issue.8, pp.781-788, 2018. ,
Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection, Pediatr Infect Dis J, vol.37, issue.1, pp.85-94, 2018. ,
Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, AIDS, vol.18, issue.14, pp.1905-1918, 2004. ,
Experience of anti-retroviral treatment for HIV-infected children in Malawi: the 1st 12 months, Ann Trop Paediatr, vol.27, issue.4, pp.261-268, 2007. ,
Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya, Pediatrics, vol.120, issue.4, pp.856-61, 2007. ,
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children, Clin Infect Dis, vol.44, issue.10, pp.1361-1368, 2007. ,
Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia, Pediatr Infect Dis J, vol.35, issue.5, pp.144-51, 2016. ,
, Use and interpretation of anthropometric indicators of nutritional status, Bull World Health Organ, vol.64, issue.6, pp.929-970, 1986.
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIVinfected children, J Infect Dis, vol.182, issue.5, pp.1385-93, 2000. ,
Prevalence and socio-demographic correlates of stunting and thinness among Pakistani primary school children, BMC Public Health, vol.11, p.790, 2011. ,
Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Study in India, ISRN Pediatr, p.763591, 2012. ,
Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa, PLoS One, vol.7, issue.3, p.33611, 2012. ,
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections, J Pediatr, vol.136, issue.6, pp.780-788, 2000. ,
Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children, Pediatr Infect Dis J, vol.20, issue.3, pp.315-321, 2001. ,
Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors, Eur J Pediatr, vol.160, issue.10, pp.611-617, 2001. ,
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial, Lancet Infect Dis, vol.12, issue.12, pp.933-974, 2012. ,
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children, Pediatrics, vol.108, issue.4, p.72, 2001. ,
Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors, Pediatr Infect Dis J, vol.22, issue.1, pp.70-76, 2003. ,
Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth, Pediatrics, vol.109, issue.2, p.25, 2002. ,
Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya, J Acquir Immune Defic Syndr, vol.43, issue.4, pp.418-443, 2006. ,
Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda, AIDS Patient Care STDS, vol.22, issue.3, pp.245-51, 2008. ,
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group, N Engl J Med, vol.324, issue.15, pp.1018-1043, 1991. ,
Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency, AIDS, vol.13, issue.1, pp.81-88, 1999. ,
, Working Group on Using Weight and Height References in Evaluating the Growth Status of Thai Children. Manual on Using Weight and Height References in Evaluation in Growth Status of Thai Children. Bangkok: Department of Health, 2000.
, Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, Centers for Disease Control and Prevention, vol.41, pp.1-19, 1992.
, Revised classification system for human immunodeficiency virus infection in children less than 13 years of age; Official authorized addenda: human immunodeficiency virus infection codes and official guidelines for coding and reporting ICD-9-CM, MMWR, vol.43, issue.12, pp.1-19, 1994.
Maximum likelihood estimation in nonlinear mixed effects models, Comput Stat Data Anal, vol.49, issue.4, pp.1020-1058, 2005. ,
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R, Comput Methods Programs Biomed, vol.90, issue.2, pp.154-66, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00274332
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models, AAPS J, vol.13, issue.2, pp.143-51, 2011. ,
Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors, Pediatr Infect Dis J, vol.16, issue.10, pp.968-74, 1997. ,
Growth response to antiretroviral treatment in HIVinfected children: a cohort study from Lilongwe, Trop Med Int Health, vol.15, issue.8, pp.934-978, 2010. ,
Younger age at HAART initiation is associated with more rapid growth reconstitution, AIDS, vol.25, issue.3, pp.345-55, 2011. ,
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus, J Pediatr, vol.162, issue.6, pp.1138-1183, 2013. ,
Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort, Pediatr Infect Dis J, vol.34, issue.7, pp.159-68, 2015. ,
Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis, AIDS, vol.29, issue.15, pp.2009-2032, 2015. ,
Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe, Int J Epidemiol, vol.46, issue.2, pp.453-65, 2017. ,
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Lancet Infect Dis, vol.11, issue.4, pp.273-83, 2011. ,
Growth and pubertal development in children and adolescents: effects of diet and physical activity, Am J Clin Nutr, vol.72, issue.2, pp.521-529, 2000. ,
Size at birth and gestational age as predictors of adult height and weight, Epidemiology, vol.16, issue.2, pp.175-81, 2005. ,
Advances in pubertal growth and factors influencing it: Can we increase pubertal growth?, Indian J Endocrinol Metab, vol.18, issue.1, pp.53-62, 2014. ,
Impact of HAART on growth and hospitalization rates among HIV-infected children, J Pediatr, vol.87, issue.2, pp.131-138, 2011. ,
Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children, J Acquir Immune Defic Syndr, vol.45, issue.3, pp.311-318, 2007. ,
Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study, BMC Infect Dis, vol.11, p.54, 2011. ,
Height, weight, and growth in children born to mothers with HIV-1 infection in, Europe. Pediatrics, vol.111, issue.1, pp.52-60, 2003. ,
Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children, AIDS, vol.24, issue.1, pp.139-185, 2010. ,
Final Height and Associated Factors in Perinatally HIVinfected Asian Adolescents, Pediatr Infect Dis J, vol.35, issue.2, pp.201-205, 2016. ,
Impact on weight and height with the use of HAART in HIV-infected children, Pediatr Infect Dis J, vol.26, issue.4, pp.334-342, 2007. ,
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents, AIDS Research and Therapy, vol.12, pp.1-9, 2014. ,
Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, Medicine, vol.95, issue.9, pp.1-9, 2016. ,
, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, Geneva: World, 2013.
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations